These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29342319)

  • 1. Validation of The Individualized Neuromuscular Quality of Life in Japanese patients with myotonic dystrophy.
    Fujino H; Saito T; Takahashi MP; Takada H; Nakayama T; Ogata K; Rose MR; Imura O; Matsumura T
    Muscle Nerve; 2018 Jan; ():. PubMed ID: 29342319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Individualized Neuromuscular Quality of Life Questionnaire in Korean Patients With Genetic Neuromuscular Diseases.
    Han HJ; Lee SA; Choi YC; Rose MR; Park HJ
    J Clin Neurol; 2022 Sep; 18(5):514-521. PubMed ID: 36062768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myotonic dystrophy health index: Japanese adaption and validity testing.
    Mori I; Fujino H; Matsumura T; Takada H; Ogata K; Nakamori M; Innami K; Shingaki H; Imura O; Takahashi MP; Heatwole C
    Muscle Nerve; 2019 May; 59(5):577-582. PubMed ID: 30681157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic dystrophy patient preferences in patient-reported outcome measures.
    Heatwole C; Johnson N; Dekdebrun J; Dilek N; Eichinger K; Hilbert J; Luebbe E; Martens W; Mcdermott MP; Thornton C; Moxley R
    Muscle Nerve; 2018 Jan; ():. PubMed ID: 29328504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and subjective symptom impact in Japanese patients with myotonic dystrophy type 1.
    Fujino H; Saito T; Takahashi MP; Takada H; Nakayama T; Imura O; Matsumura T
    BMC Neurol; 2022 Feb; 22(1):55. PubMed ID: 35164706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases.
    Sansone VA; Panzeri M; Montanari M; Apolone G; Gandossini S; Rose MR; Politano L; Solimene C; Siciliano G; Volpi L; Angelini C; Palmieri A; Toscano A; Musumeci O; Mongini T; Vercelli L; Massa R; Panico MB; Grandi M; Meola G
    Eur J Neurol; 2010 Sep; 17(9):1178-1187. PubMed ID: 20374278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective measurement of quality of life in myotonic dystrophy type 1.
    Peric S; Heatwole C; Durovic E; Kacar A; Nikolic A; Basta I; Marjanovic A; Stevic Z; Lavrnic D; Rakocevic Stojanovic V
    Acta Neurol Scand; 2017 Dec; 136(6):694-697. PubMed ID: 28660733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in patients with myotonic dystrophy type 2.
    Rakocevic Stojanovic V; Peric S; Paunic T; Pesovic J; Vujnic M; Peric M; Nikolic A; Lavrnic D; Savic Pavicevic D
    J Neurol Sci; 2016 Jun; 365():158-61. PubMed ID: 27206898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The individualized neuromuscular quality of life questionnaire: cultural translation and psychometric validation for the Dutch population.
    Seesing FM; van Vught LE; Rose MR; Drost G; van Engelen BG; van der Wilt GJ
    Muscle Nerve; 2015 Apr; 51(4):496-500. PubMed ID: 25042897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Translation and validation of the Individualised Neuromuscular Quality of Life scale for the Spanish population: quality of life assessment for persons with neuromuscular diseases].
    Fagoaga J; Girabent-Farres M; Bagur-Calafat C
    Rev Neurol; 2017 Mar; 64(5):194-200. PubMed ID: 28229439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Myotonic Dystrophy Health Index: Italian validation of a disease-specific outcome measure.
    Sansone VA; Lizio A; Greco L; Gragnano G; Zanolini A; Gualandris M; Iatomasi M; Heatwole C
    Neuromuscul Disord; 2017 Nov; 27(11):1047-1053. PubMed ID: 28890289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1.
    Rakocevic-Stojanovic V; Peric S; Madzarevic R; Dobricic V; Ralic V; Ilic V; Basta I; Nikolic A; Stefanova E
    Clin Neurol Neurosurg; 2014 Nov; 126():76-81. PubMed ID: 25215445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the individualised neuromuscular quality of life for the USA with comparison of the impact of muscle disease on those living in USA versus UK.
    Sadjadi R; Vincent KA; Carr AJ; Walburn J; Brooks VL; Pandya S; Kissel JT; Jackson CE; Rose MR;
    Health Qual Life Outcomes; 2011 Dec; 9():114. PubMed ID: 22177525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cultural adaptation and validation of the Norwegian version of the swallowing quality of life questionnaire (SWAL-QOL).
    Rivelsrud MC; Kirmess M; Hartelius L
    Health Qual Life Outcomes; 2019 Dec; 17(1):179. PubMed ID: 31805954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease burden of myotonic dystrophy type 1.
    Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Gorman G; Turner C; Lochmüller H
    J Neurol; 2019 Apr; 266(4):998-1006. PubMed ID: 30788616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL).
    Vincent KA; Carr AJ; Walburn J; Scott DL; Rose MR
    Neurology; 2007 Mar; 68(13):1051-7. PubMed ID: 17389311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-cultural adaptation and validation of the Japanese version of the new Knee Society Scoring System for osteoarthritic knee with total knee arthroplasty.
    Hamamoto Y; Ito H; Furu M; Ishikawa M; Azukizawa M; Kuriyama S; Nakamura S; Matsuda S
    J Orthop Sci; 2015 Sep; 20(5):849-53. PubMed ID: 25982223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. French validation of the Stroke Specific Quality of Life Scale (SS-QoL).
    Legris N; Devilliers H; Daumas A; Carnet D; Charpy JP; Bastable P; Giroud M; Béjot Y
    NeuroRehabilitation; 2018; 42(1):17-27. PubMed ID: 29400672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependent and paranoid personality patterns in myotonic dystrophy type 1.
    Peric S; Sreckov M; Basta I; Lavrnic D; Vujnic M; Marjanovic I; Rakocevic Stojanovic V
    Acta Neurol Scand; 2014 Apr; 129(4):219-25. PubMed ID: 24032453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation, reliability, and validity of the Norwegian version of the ABILHAND-NMD and the ACTIVLIM for Myotonic Dystrophy type 1.
    Fossmo HL; Ørstavik K; Frich JC; Robinson HS
    Disabil Rehabil; 2024 Jun; 46(12):2699-2707. PubMed ID: 37438996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.